What BUGWORKS Research does
Founded in 2014, BUGWORKS Research operates in Health Tech industry. Initially concentrating on drug discovery for bacterial infections, the company has evolved its offerings to include a broader pipeline of anti-infective therapies. BUGWORKS announced a successful advancement of its flagship antibiotic compound through Phase 1 clinical trials, marking a significant milestone in its journey to address global health challenges. The company is further expanding its R&D capabilities with strategic collaborations in new geographical markets. Competing with companies such as Pandorum Technologies and String Bio.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about BUGWORKS Research yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.